REFERENCES:

1. Ligon AH, Morton CC. Leiomyomata: heritability and cytogenetic studies. Hum
Reprod Update 2001;7(1):8-14.
2. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J
Obstet Gynaecol 1990;97(4):285-98.
3. Fields K, Neinstein L. Uterine myomas in adolescents: case reports and a review
of the literature. J Pediatr Adolesc Gynecol 1996;9(4):195-8.
4. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol
1990;94(4):435-8.
5. Deligdish L, Loewenthal M. Endometrial changes associated with myomata of the
uterus. J Clin Pathol 1970;23(8):676-80.
6. Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the
pathogenesis of uterine myomas. Am J Obstet Gynecol 1995;172(1):14-8.
7. Jha R, Pant AD, Jha A, Adhikari RC, Sayami G. Histopathological analysis of
hysterectomy specimens. J Nepal Med Assoc 2006;45(163):283-90.
8. Urogenital system. In: Sadler TW, editor. Langman's Medical Embryology. 11th
ed. New Delhi: Lippincott Williams and Wilkins; 2010. p.235-62.
9. Ferenczy A. Anatomy and Histology of the Uterine Corpus. In: Kurman RJ, editor.
Blausteins Pathology of the Female Genital Tract. 4th ed. New York: Springer;
1994. p.327-66.
10. Female reproductive system. In: Rosai J, editor. Rosai and Ackerman's Surgical
Pathology. 10th ed. New Delhi: Elsevier; 2011. p.1477-519.
11. Ind T. Uterus. In: Standring S, editor. Gray's Anatomy. 39th ed. London: Elsevier
Churchill Livingstone; 2005. p.1331-8.
12. Bentley RC, Mutter GL, Robboy SJ. The Normal Histology of the Endometrium.
In: Mutter GL, Prat J, editors. Histopathology of the Endometrium. 3rd ed.
London: Elsevier; 2014. p.290-5.
13. The Normal Histology of the Endometrium. In: Hellweg GD, editor.
Histopathology of the Endometrium. 4th ed. New York: Springer; 1987. p.25-92.
14. Bulmer JN, Hollings D, Ritson A. Immunocytochemical evidence that endometrial
stromal granulocytes are granulated lymphocytes. J Pathol 1987;153(3):281-8.
75

15. Hendrickson MR, Longacre TA, Kempson RL. The uterine corpus. In: Mills SE,
Carter D, Greenson JK, Oberman HA, Reuter VE, Stoler MH, editors. Sternberg's
Diagnostic Surgical Pathology. 4th ed. Philadelphia: Lippincott Williams &
Wilkins; 2004. p.2435-542.
16. Booker SS, Jayanetti C, Karalak S, Hsiu J-G, Archer DF. The effect of
progesterone on the accumulation of leukocytes in the human endometrium. Am J
Obstet Gynecol 1994;171(1):139-42.
17. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet
Gynecol 1975;122(2):262-3.
18. Mylonas I, Jeschke U, Shabani N, Kuhn C, Kunze S, Dian D, et al. Steroid
receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal
and atrophic human endometrium. Histol Histopathol 2007;22(2):169-76.
19. Taylor LJ, Jackson TL, Reid JG, Duffy SR. The differential expression of
oestrogen receptors, progesterone receptors, Bcl2 and Ki67 in endometrial
polyps. BJOG 2003;110(9):794-8.
20. Alsbach GP, Franck ER, Poortman J, Thijssen JH. Subcellular distribution of
estradiol and estrone in human endometrium and myometrium during the
menstrual cycle. Contraception 1983;27(4):409-21.
21. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS.
Immunohistochemical analysis of human uterine estrogen and progesterone
receptors

throughout

the

menstrual

cycle.

Clin

Endocrinol

Metab

1988;67(2):334-40.
22. Snijders MP, de Goeij AF, Debets-Te Baerts MJ, Rousch MJ, Koudstaal J, Bosman
FT. Immunocytochemical analysis of oestrogen receptors and progesterone
receptors in the human uterus throughout the menstrual cycle and after the
menopause. J Reprod Fertil 1992;94(2):363-71.
23. Leroy F, Manavian D, Hubinont PO. Nuclear DNA estimations in the Hooker and
Forbes test with sex hormones. J Endocrinol 1967;39(2):227-31.
24. Montgomery BE, Daum GS, Dunton CJ. Endometrial hyperplasia: a review.
Obstet Gynecol Surv 2004;59(5):368-78.
76

25. Ellenson LH, Pirog EC. The Female Genital Tract. In: Kumar V, Abbas AK,
Fausto N, Aster JC, editors. Robbins and Cotran Pathologic Basis of Disease. 8th
ed. Philadelphia: Elsevier; 2010. p.1005-63.
26. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A
long-term study of untreated hyperplasia in 170 patients. Obstet Gynecol Surv
1986;41(1):58-61.
27. Lacey JV, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, Duggan MA, et al.
Absolute risk of endometrial carcinoma during 20-year follow-up among women
with endometrial hyperplasia. J Clin Oncol 2010;28(5):788-92.
28. Giudice LC. Endometriosis. N Engl J Med 2010;362(25):2389-98.
29. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis.
Fertility and sterility 2012;98(3):511-9.
30. Sourial S, Tempest N, Hapangama DK. Theories on the Pathogenesis of
Endometriosis. International Journal of Reproductive Medicine 2014;2014:
179515. doi: 10.1155/2014/179515.
31. Evans JM. An Integrative Approach to Fibroids, Endometriosis, and Breast Cancer
Prevention. Integrative Medicine 2008;7(5):28-31.
32. Mathur BB, Shah BS, Bhende YM. Adenomyosis uteri. A pathologic study of 290
cases. Am J Obstet Gynecol 1962;84:1820-9.
33. Townsend DE, Sparkes RS, Baluda MC, McClelland G. Unicellular histogenesis
of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate
dehydrogenase. Am J Obstet Gynecol 1970;107(8):1168-73.
34. Bozini N, Baracat EC. The history of myomectomy at the Medical School of
University of Sao Paulo. Clinics 2007;62(3):209-10.
35. Pradhan P, Acharya N, Kharel B, Manjin M. Uterine myoma: a profile of Nepalese
women. N J Obst Gynaecol 2006;1(2):47-50.
36. Haney AF. Clinical decision making regarding leiomyomata: what we need in the
next millenium. Environ Health Perspect 2000;108(Suppl 5):835-9.
37. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy
in the United States, 1988-1990. Obstet Gynecol 1994;83(4):549-55.

77

38. Gambone JC, Reiter RC, Lench JB, Moore JG. The impact of a quality assurance
process on the frequency and confirmation rate of hysterectomy. Am J Obstet
Gynecol 1990;163(2):545-50.
39. Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N,
Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on
surgically treated uterine leiomyomas: a multicentre case--control study. Br J
Obstet Gynaecol 1996;103(9):909-14.
40. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz
GA, et al. Variation in the incidence of uterine leiomyoma among premenopausal
women by age and race. Obstet Gynecol 1997;90(6):967-73.
41. Nibert M, Heim S. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer
1990;2(1):3-13.
42. Makinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, et al.
MED12, the mediator complex subunit 12 gene, is mutated at high frequency in
uterine leiomyomas. Science 2011;334(6053):252-5.
43. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract
Res Clin Obstet Gynaecol 2008;22(4):571-88.
44. Rein MS. Advances in uterine leiomyoma research: the progesterone hypothesis.
Environ Health Perspect 2000;108(Suppl 5):791-3.
45. Neiger R, Sonek JD, Croom CS, Ventolini G. Pregnancy-related changes in the
size of uterine leiomyomas. J Reprod Med 2006;51(9):671-4.
46. Richards PA, Tiltman AJ. Anatomical variation of the oestrogen receptor in the
non-neoplastic

myometrium

of

fibromyomatous

uteri.

Virchows

Arch

1996;428(6):347-51.
47. Strissel PL, Swiatek J, Oppelt P, Renner SP, Beckmann MW, Strick R.
Transcriptional analysis of steroid hormone receptors in smooth muscle uterine
leiomyoma tumors of postmenopausal patients. J Steroid Biochem Mol Biol
2007;107(1-2):42-7.

78

48. Massart F, Becherini L, Marini F, Noci I, Piciocchi L, Del Monte F, et al. Analysis
of estrogen receptor (ERalpha and ERbeta) and progesterone receptor (PR)
polymorphisms in uterine leiomyomas. Med Sci Monit 2003;9(1):25-30.
49. Fischer C, Juhasz-Boess I, Lattrich C, Ortmann O, Treeck O. Estrogen receptor
beta gene polymorphisms and susceptibility to uterine fibroids. Gynecol
Endocrinol 2010;26(1):4-9.
50. Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptor-alpha
polymorphism is associated with a higher prevalence of uterine leiomyomas in
black Americans. Fertil Steril 2006;86(3):686-93.
51. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine
leiomyoma growth and apoptosis. Hum Reprod Update 2004;10(3):207-20.
52. Yen-Ping Ho J, Man WC, Wen Y, Polan ML, Shih-Chu Ho E, Chen B.
Transforming growth interacting factor expression in leiomyoma compared with
myometrium. Fertil Steril 2010;94(3):1078-83.
53. Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis
updated for the molecular era. Hum Reprod Update 1996;2(4):295-306.
54. Exacoustos C, Rosati P. Ultrasound diagnosis of uterine myomas and
complications in pregnancy. Obstet Gynecol 1993;82(1):97-101.
55. Greene JF, DeRoche ME, Ingardia C, Curry SL. Large myomatous uterus
resulting in complete obstruction of the inferior vena cava during pregnancy.
BJOG 2002;109(10):1189-91.
56. Wilkinson N, Rollason TP. Recent advances in the pathology of smooth muscle
tumours of the uterus. Histopathology 2001;39(4):331-41.
57. Hendrickson MR, Tavassoli FA, Kempson RL, McCluggage WG, Haller U,
Kubik-Huch RA. Mesenchymal tumors and related lesions. In: Tavassoli FA,
Devilee P, editors. Pathology and genetics of tumours of the Female Genital
Organs. 3rd ed. Lyon: IARC Press; 2003. p.223-44.
58. Kawaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogaki H, Mori T. Mitotic activity
in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol
1989;160(3):637-41.

79

59. Low SC, Chong CL. A case of cystic leiomyoma mimicking an ovarian
malignancy. Ann Acad Med Singapore 2004;33(3):371-4.
60. Murase E, Siegelman ES, Outwater EK, Perez-Jaffe LA, Tureck RW. Uterine
leiomyomas: histopathologic features, MR imaging findings, differential
diagnosis, and treatment. Radiographics 1999;19(5):1179-97.
61. Persaud V, Arjoon PD. Uterine leiomyoma: incidence of degenerative change and
a correlation of associated symptoms. Obstet Gynecol 1970;35(3):432-6.
62. Ueda H, Togashi K, Konishi I, Kataoka ML, Koyama T, Fujiwara T, et al. Unusual
appearances

of

uterine

leiomyomas:

MR

imaging

findings

and

their

histopathologic backgrounds. Radiographics 1999;19(Suppl 1):S131-45.

63. Clement PB, Young RH, Scully RE. Diffuse, perinodular, and other patterns of
hydropic degeneration within and adjacent to uterine leiomyomas. Problems in
differential diagnosis. Am J Surg Pathol 1992;16(1):26-32.
64. Han SC, Kim MD, Jung DC, Lee M, Lee MS, Park SI, et al. Degeneration of
leiomyoma in patients referred for uterine fibroid embolization: incidence,
imaging features and clinical characteristics. Yonsei Med J 2013;54(1):215-9.
65. Hwang JH, Modi GV, Jeong Oh M, Lee NW, Hur JY, Lee KW, et al. An unusual
presentation of a severely calcified parasitic leiomyoma in a postmenopausal
woman. JSLS 2010;14(2):299-302.
66. O'Connor DM, Norris HJ. Mitotically active leiomyomas of the uterus. Hum
Pathol 1990;21(2):223-7.
67. Oliva E, Young RH, Clement PB, Bhan AK, Scully RE. Cellular benign
mesenchymal tumors of the uterus. A comparative morphologic and
immunohistochemical analysis of 33 highly cellular leiomyomas and six
endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol
1995;19(7):757-68.
68. Norris HJ, Hilliard GD, Irey NS. Hemorrhagic cellular leiomyomas (apoplectic
leiomyoma) of the uterus associated with pregnancy and oral contraceptives. Int J
Gynecol Pathol 1988;7(3):212-24.

80

69. Kurman RJ, Norris HJ. Mesenchymal tumors of the uterus. VI. Epithelioid smooth
muscle tumors including leiomyoblastoma and clear-cell leiomyoma: a clinical
and pathologic analysis of 26 cases. Cancer 1976;37(4):1853-65.
70. Downes KA, Hart WR. Bizarre leiomyomas of the uterus: a comprehensive
pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol
1997;21(11):1261-70.
71. Fechner RE. Atypical leiomyomas and synthetic progestin therapy. Am J Clin
Pathol 1968;49(5):697-703.
72. Pounder DJ. Fatty tumours of the uterus. J Clin Pathol 1982;35(12):1380-3.
73. Clement PB. The pathology of uterine smooth muscle tumors and mixed
endometrial stromal-smooth muscle tumors: a selective review with emphasis on
recent advances. Int J Gynecol Pathol 2000;19(1):39-55.
74. Ferry JA, Harris NL, Scully RE. Uterine leiomyomas with lymphoid infiltration
simulating lymphoma. A report of seven cases. Int J Gynecol Pathol 1989;8(3):
263-70.
75. McCluggage WG, Boyde A. Uterine angioleiomyomas: a report of 3 cases of a
distinctive benign leiomyoma variant. Int J Surg Pathol 2007;15(3):262-5.
76. Fornelli A, Pasquinelli G, Eusebi V. Leiomyoma of the uterus showing skeletal
muscle differentiation: a case report. Hum Pathol 1999;30(3):356-9.
77. Mulvany NJ, Ostor AG, Ross I. Diffuse leiomyomatosis of the uterus.
Histopathology 1995;27(2):175-9.
78. Abell MR, Littler ER. Benign metastasizing uterine leiomyoma. Multiple lymph
nodal metastases. Cancer 1975;36(6):2206-13.
79. Gowri M, Mala G, Murthy S, Nayak V. Clinicopathological study of uterine
leiomyomas in hysterectomy specimens. JEMDS 2013;2(46):9002-9.
80. Witherspoon J. The interrelationship between ovarian follicle cysts, hyperplasia of
the endometrium, and fibromyomata. Surg Gynecol Obstet 1933;56(6):1026-35.
81. Witherspoon J. The estrogenic principle, the common etiological factor of
endometrial hyperplasia, uterine fibroids and endometriomas. Surg Gynecol
Obstet 1935;61(12):743.

81

82. Szajnbok Sobrinho M, Goncalves WJ, Nicolau SM, Girao MJ, Baracat EC, Novo
NF, et al. Pathology associated with uterine leiomyoma: review of 600 cases. Rev
Paul Med 1990;108(6):252-6.
83. Juhi S, Ruchika B, Vinay B, Tanya S, Rani B, Shashi U, et al. A study of spectrum
of morphological changes in endometrium in abnormal uterine bleeding. JARBS
2013;5(4):370-5.
84. Sharma SP, Misra SD, Mittal VP. Endometrial changes -a criterion for
the diagnosis of submucous uterine leiomyoma. Indian J Pathol Microbiol
1979;22(1):33-6.
85. Patterson-Keels LM, Selvaggi SM, Haefner HK, Randolph JF. Morphologic
assessment of endometrium overlying submucosal leiomyomas. J Reprod Med
1994;39(8):579-84.
86. Chhabra S, Ohri N. Leiomyomas of uterusA clinical study. J Obstet Gynaecol
India 1993;43(3):437-39.
87. Farrer-Brown G, Beilby JO, Tarbit MH. Venous changes in the endometrium of
myomatous uteri. Obstet Gynecol 1971;38(5):743-51.
88. Farrer-Brown G, Beilby JO, Tarbit MH. The vascular patterns in myomatous uteri.
J Obstet Gynaecol Br Commonw 1970;77(11):967-75.
89. Chethana M, Kumar HML, Munikrishna M. Endometrial changes in uterine
leiomyomas. J Clin Biomed Sci 2013;3(2):72-9.
90. Mohammad A, Makaju R. Retrospective histopathological analysis of various
neoplasms of the female reproductive system (FRS) seen at the Kathmandu
University Teaching Hospital, (KUTH) Dhulikhel, Nepal. Kathmandu Univ Med J
2006;4(1):48-53.
91. Ranabhat S, Shrestha R, Tiwari M, Sinha D, Subedee L. A retrospective
histopathological study of hysterectomy with or without salpingoophorectomy
specimens. JCMC 2010;1(1):26-9.
92. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas:
a review. Environ Health Perspect 2003;111(8):1037-54.
93. Parazzini F, Negri E, La Vecchia C, Chatenoud L, Ricci E, Guarnerio P.
Reproductive factors and risk of uterine fibroids. Epidemiology 1996;7(4):440-2.
82

94. Stewart EA. Uterine fibroids. The Lancet 2001;357(9252):293-8.

95. Tripathi M, Pandit C, Sherchan A. Uterine Fibroid: A Common Cause of
Menorrhagia. A Retrospective Study at Gandaki Medical College Teaching
Hospital. Journal of Gandaki Medical College 2013;6(2):1-4.
96. Sajjad M, Iltaf S, Qayyum S. Pathological findings in Hysterectomy specimens of
patients presenting with menorrhagia in different age groups. Ann Pak Inst Med
Sci 2011;7(3):160-2.
97. Cramer S, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol
1990;94(4):435-8.
98. Velu A RK, Srinivasamurthy BC, Sundaram A. Uterine fibroid tumours and
associated changes in endometrium and myometrium: A three year prospective
study in a tertiary care hospital. J Pharm Biomed Sci 2014;4(9):797-805.
99. Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical
features, and management. Obstet Gynecol 2004;104(2):393-406.
100. Miura S, Khan KN, Kitajima M, Hiraki K, Moriyama S, Masuzaki H, et al.
Differential infiltration of macrophages and prostaglandin production by different
uterine leiomyomas. Hum Reprod 2006;21(10):2545-54.
101. Teleman S, Mihailovici MS. Morphological correlations between endometrial
hyperplasias, uterine leiomyoma and ovarian associated lesions. Rev Med Chir
Soc Med Nat Iasi 2003;107(2):379-82.
102. Ciavattini A, Di Giuseppe J, Stortoni P, Montik N, Giannubilo SR, Litta P, et
al. Uterine fibroids: pathogenesis and Interactions with endometrium and
endomyometrial

junction.

Obstet

Gynecol

Int

2013;2013:173184.

doi:

10.1155/2013/173184
103. Rowlands IJ, Nagle CM, Spurdle AB, Webb PM. Gynecological conditions
and the risk of endometrial cancer. Gynecol Oncol 2011;123(3):537-41.
104. Jargalsaikhan B, Galtsog L, Erdenetsogt D, Yanjinsuren D. Endometrial
epithelial cell changes associated with uterine leiomyoma. Mongolian Journal of
Health Sciences 2013;10(1):39-42.
105. Rizvi G, Pandey H, Pant H, Chufal SS, Pant P. Histopathological correlation
of adenomyosis and leiomyoma in hysterectomy specimens as the cause of
83

abnormal uterine bleeding in women in different age groups in the Kumaon

region: A retroprospective study. J Midlife Health 2013;4(1):27-30.
106. Raju GC, Naraynsingh V, Woo J, Jankey N. Adenomyosis uteri: a study of 416
cases. Aust N Z J Obstet Gynaecol 1988;28(1):72-3.
107. Manjula K, Rao SK, Chandrasekhar HR. Variants of Leiomyoma:
Histomorphological Study of Tumors of Myometrium. J S Asian Fed Obstet
Gynecol 2011;3(2):89-92.
108. Manjula K, Rao SK, Chandrasekhar HR. Histomorphological Study of
Degenerative Changes in Leiomyoma of Myometrium. NJBMS 2010;1(2):70-5.

84